XKRFYHLGVUSROY-UHFFFAOYSA-N argon Chemical compound XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 110.238000002360 preparation method Methods 0.000 title claims description 16.DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton(0) Chemical compound DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 title claims description 88.229910052743 krypton Inorganic materials 0.000 title claims description 88. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from NL2545778X external-priority Application filed by Directie van de Staatsmijnen in Limburg filed Critical Directie van de Staatsmijnen in Limburg Application granted granted Critical Publication of US2545778A publication Critical patent/US2545778A/en Anticipated expiration legal-status Critical Status Expired - Lifetime legal-status Critical Current Links Original Assignee Directie van de Staatsmijnen in Limburg Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Inventor Haringhuizen Pieter Jan Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Expired - Lifetime Application number US56512A Other languages English ( en) Google Patents Process for the preparation of krypton-rich gasesÄownload PDF Info Publication number US2545778A US2545778A US56512A US5651248A US2545778A US 2545778 A US2545778 A US 2545778A US 56512 A US56512 A US 56512A US 5651248 A US5651248 A US 5651248A US 2545778 A US2545778 A US 2545778A Authority US United States Prior art keywords gas krypton methane fraction argon Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US2545778A - Process for the preparation of krypton-rich gases US2545778A - Process for the preparation of krypton-rich gases
0 Comments
Leave a Reply. |